Kasim Kutay

Kasim Kutay is currently Chief Executive Officer at Novo Holdings A since 2016, CEO at Novo Principal Investments since 2016, Non-Independent Director at Novo Nordisk A since 2017, Director at Momentum Energy Group A, Director at Chelsea & Westminster Hospital NHS Foundation Trust, and Non-Independent Director at Novonesis (Novozymes A) since 2024.
Former roles include Chairman-European Healthcare Group at Morgan Stanley & Co. LLC from 1989 to 2007, Managing Director & Co-Head-Europe at Moelis & Co. LLC from 2009 to 2016, Managing Director at Moelis Asset Management LP, Director at Active Biotech AB, Director at Novo Nordisk Ltd., Managing Director & Head-Financial Solutions at Sun Group Global from 2007 to 2009, Managing Director at Moelis & Company UK LLP from 2009 to 2016, Non-Executive Director at Convatec Group Plc from 2017 to 2018, Director at Novozymes A, Member-Supervisory Board at Evotec SE, Trustee at Northwick Park Institute For Medical Research from 2005 to 2016, and Member-Governors Board at School of Oriental & African Studies from 2006 to 2011.
Education includes undergraduate and graduate degrees from London School of Economics & Political Science, conferred in 1986 and 1987 respectively.